Navigation Links
The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation
Date:3/2/2011

BEVERLY HILLS, Calif., March 2, 2011 /PRNewswire/ -- The Center for Radiation Therapy of Beverly Hills, a state-of-the-art cancer treatment center serving cancer patients in the Los Angeles area, has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR) and The American Society for Radiation Oncology (ASTRO).

Radiation oncology (radiation therapy) is the careful use of high-energy radiation to treat cancer. A radiation oncologist may use radiation to cure cancer or to relieve a cancer patient's pain.

The ACR-ASTRO seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific practice guidelines and technical standards developed by ACR and ASTRO after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed in the review process. The findings are reported to the ACR-ASTRO Committee on Radiation Oncology Accreditation, which subsequently provides the practice with a comprehensive report it can use for continuous practice improvement.

The Center for Radiation Therapy of Beverly Hills, part of the Tower Hematology Oncology Medical Group, voluntarily underwent the rigorous review process to ensure the practice meets nationally accepted standards of care as determined by ACR. It is the first free-standing radiation center in California, and only the second radiation facility of any kind in the Los Angeles area, to earn the accreditation.

"We are honored to receive this prestigious accreditation, which acknowledges that the center's medical personnel are well qualified, through education and certification, to administer radiation therapy treatments," said Christopher M. Rose, M.D., Medical Director of The Center for Radiation Therapy of Beverly Hills and Chief Technology Officer of Valley Radiotherapy Associates. "We look forward to continuing to offer patients the most effective and up-to-date treatment options, and providing care that meets the highest quality standards."

Barry Rosenbloom, M.D., Managing Partner of the Tower Hematology Oncology Medical Group, said the accreditation reflects the entire group's commitment to safety and unsurpassed patient care.

"Earning the ACR-ASTRO accreditation ensures our patients that they will receive appropriate treatment from skilled medical professionals using superbly maintained equipment, in a facility that meets the most demanding professional benchmarks for safety and quality assurance," Dr. Rosenbloom asserted.

The ACR is a national professional organization serving more than 34,000 diagnostic and interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists, with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services. ASTRO is a professional organization serving more than 10,000 radiation oncologists, medical physicists, and other health care professionals involved in the treatment of cancer patients.

About The Center for Radiation Therapy of Beverly Hills

Established in 2006 by Tower Hematology Oncology Medical Group, The Center for Radiation Therapy of Beverly Hills (RTBH) is centrally located in the heart of Beverly Hills and adjacent to the cities of Santa Monica and Los Angeles. RTBH provides oncology patients with state-of-the-art radiation therapy care by a team of highly trained and experienced clinicians. Its above-ground design creates a highly accessible treatment environment. RTBH was the first treatment center in Southern California to implement RapidArc™ radiotherapy technology from Varian Medical Systems, a revolutionary breakthrough in cancer treatment that delivers powerful tumor-destroying radiation with unprecedented speed and remarkable precision. For more information, please visit www.rtbh.net.

About Valley Radiotherapy Associates Medical Group, Inc.

Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver quality radiation oncology services. Today, Manhattan Beach, Calif.-based VRA has 34 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California and Denver, Colorado. VRA has distinguished itself during the past 25 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valley-radiotherapy.com.


'/>"/>
SOURCE The Center for Radiation Therapy of Beverly Hills
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
7. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
8. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
(Date:6/9/2017)... and INDIANAPOLIS , June ... are living with diabetes. In a further effort to ... people affected by this condition, the International Diabetes Federation ... LLY ) have come together for the second phase ... and Systems programme (BRIDGES 2), reaffirming their commitment to ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. ... Medicine Specialists, in collaboration with the Fertility Center of California, is pleased to ... (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These minimally invasive ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... ... ... KICKICO , a protocol built on Ethereum for more transparent ICO ... within funding campaigns. KICKICO developers are testing the platform, which will launch for the ... funds through the power of many - has been around for about ten years ...
(Date:6/25/2017)... ... 24, 2017 , ... Create a feel-good lyric music video in Final Cut Pro X with ... timeline and write in the lyrics to any song. ProLyric flies in the text for ... the text can be added modularly for optimal control. ProLyric makes editing any music video ...
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
Breaking Medicine News(10 mins):